Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.58 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.58 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.58 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.56 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12464189 | 0.94 | TDP1 (0.68) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| SCHEMBL17867451 | 0.93 | L3MBTL1 (0.71) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| SCHEMBL1122004 | 0.93 | L3MBTL1 (0.71) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| Benzene SCHEMBL27311002 | 0.88 | TRPA1 (0.58) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| SCHEMBL725762 | 0.88 | TRPA1 (0.58) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| SCHEMBL10420753 | 0.87 | L3MBTL1 (0.62) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| SCHEMBL31351852 | 0.86 | KMT2A (0.52) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| SCHEMBL23782435 | 0.85 | MMP1 (0.56) | L3MBTL1TDP1MAPTLMNANPC1 | |
| SCHEMBL5696497 | 0.85 | L3MBTL1 (0.60) | L3MBTL1TDP1MAPTLMNAHDAC1 | |
| SCHEMBL28613349 | 0.85 | L3MBTL1 (0.60) | L3MBTL1TDP1MAPTLMNAHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0254432-A2 | Method of preparing alpha-arylalkanoic esters | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1988-01-27 | — | — | EP | claimed |
| JP-57163337-A | — | — | None | — | — | JP | disclosed |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | disclosed |
| US-20240238461-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | JANSSEN BIOTECH, INC. | 2024-07-18 | — | — | US | disclosed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-9579325-B2 | Modulators of TNF-α signaling | GENZYME CORPORATION (US) | 2017-02-28 | — | — | US | disclosed |
| US-9579325-B2 | Modulators of TNF-α signaling | GENZYME CORPORATION (US) | 2017-02-28 | — | — | US | disclosed |
| US-20150126512-A1 | Modulators Of TNF-Alpha Signaling | GENZYME CORPORATION (US) | 2015-05-07 | — | — | US | disclosed |
| US-8921547-B2 | Modulators of TNF-α signaling | GENZYME CORPORATION (US) | 2014-12-30 | — | — | US | disclosed |
| US-20130310388-A1 | Modulators of TNF-Alpha Signaling | GENZYME CORPORATION (US) | 2013-11-21 | — | — | US | disclosed |
| WO-1995014012-A1 | 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |
| WO-1995014011-A2 | 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |
| US-5250546-A | Administering as therapy for spastic paralysis; glutamic acid blocking agent; agricultural chemicals | NIPPON CHEMIPHAR CO., LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0177245-B1 | AMINO-ALCOHOL DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | NIPPON CHEMIPHAR CO., LTD. (JP) | 1991-04-10 | — | — | EP | disclosed |
| EP-0254432-A2 | Method of preparing alpha-arylalkanoic esters | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1988-01-27 | — | — | EP | disclosed |
| EP-0048136-B1 | PROCESS FOR PREPARING ALPHA-AROMATIC GROUP SUBSTITUTED ALKANOIC ACIDS OR ESTERS THEREOF | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1986-06-11 | — | — | EP | disclosed |
| EP-0177245-A2 | Amino-alcohol derivatives and processes for their preparation | NIPPON CHEMIPHAR CO., LTD. (JP) | 1986-04-09 | — | — | EP | disclosed |
| JP-S57163337-A | PREPARATION OF PROPIONIC ACID DERIVATIVE | KYOWA HAKKO KOGYO CO LTD | 1982-10-07 | — | — | JP | disclosed |
| US-4149413-A | THERMOCHROMIC | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHER IRELAND (GB) | 1979-04-17 | — | — | US | disclosed |
| US-4071448-A | FORMALDEHYDE, HEATING IN OXYGEN, DECOMPOSITION, NONTOXIC PRODUCTS | MITSUI TOATSU CHEMICALS, INCORPORATED (JA) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | L3MBTL1 4285/4885TDP1 69/4885MAPT 3235/4885 |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | BCL2, BAX, EPCAM | L3MBTL1 99/4885TDP1 3602/4885MAPT 3088/4885 |
| US-20240238461-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | BDNF, CD47, MAG | L3MBTL1 2509/4885TDP1 1821/4885MAPT 140/4885 |
| US-20150126512-A1 | Modulators Of TNF-Alpha Signaling | TNF, TNFRSF1A, TNFRSF9 | L3MBTL1 4543/4885TDP1 3459/4885MAPT 3308/4885 |
| US-20130310388-A1 | Modulators of TNF-Alpha Signaling | TNF, TNFRSF1A, TNFRSF9 | L3MBTL1 4543/4885TDP1 3459/4885MAPT 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.